Initial Study Sample Clauses

Initial Study. A study of a Completed Application conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Section 19 or Section 32 of the Tariff. Interconnected Entity: Either the Interconnection Customer or the Interconnected Transmission Owner; Interconnected Entities shall mean both of them. Interconnected Transmission Owner: The Transmission Owner to whose transmission facilities or distribution facilities Customer Interconnection Facilities are, or as the case may be, a Customer Facility is, being directly connected. When used in an Interconnection Construction Service Agreement, the term may refer to a Transmission Owner whose facilities must be upgraded pursuant to the Facilities Study, but whose facilities are not directly interconnected with those of the Interconnection Customer.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Initial Study. In the Initial Study, ICF will disclose each of the CEQA environmental topics to determine which would require additional discussion in the focused EIR, and which would present no change from what was previously analyzed in the ConnectMenlo EIR. For efficiency and consistency with other City documents, the Initial Study will follow the same format as the 1125 O’Brien Drive Project Initial Study.  Aesthetics – Aesthetic impacts were determined to be less than significant in the ConnectMenlo Draft EIR. The Project would include increased development intensity; therefore, the buildings would have more mass, bulk, height, lighting, and/or glare, resulting in potentially greater visual impacts. Upon receipt of site plans, building elevations, and/or visual simulations (if available) prepared by the Project Sponsor, ICF will determine whether the Project would result in conflicts with existing plans and policies protecting aesthetic resources, as compared to what was analyzed in the ConnectMenlo EIR. However, it is not expected that impacts would be greater than those previously analyzed.  Agricultural and Forestry Resources – No agricultural or forestry resources currently exist at the Project site. Therefore, no impacts would occur.  Air Quality – It is anticipated that all of the air quality topics will be discussed in the EIR, rather than in the Initial Study (see Task 6, below).  Biological Resources – The Project site is within an urban setting and is bordered on all sides by the Menlo Park Labs campus and industrial/warehousing uses. Although the Project site is near the Bay and the Xxx Xxxxxxx San Francisco Bay National Wildlife Refuge, it is separated by Xxxxx Xxxxx 00 and, therefore, is not expected to have an impact on special-status species inhabiting these areas. The Project site is currently developed with buildings and surface parking lots. Trees line the southern of the Project site, along O’Brien Drive, which could provide habitat for nesting birds. The Initial Study would consider potential impacts to nesting birds during construction. This scope assumes that the applicant will provide a Biological Resources Assessment (BRA), per Mitigation Measure BIO-1 from the ConnectMenlo EIR. ICF will review the BRA and incorporate it into the Initial Study.
Sample 1
Initial Study. ICF Xxxxx & Xxxxxx would be responsible for preparing an IS to assist the City in determining the appropriate CEQA document for the proposed project. ICF Xxxxx & Xxxxxx would be responsible for preparing a Water Supply Assessment, the results of which would be summarized in the IS. Our subconsultant, Xxxx & Peers, would be responsible for preparing the traffic study, the results of which would be summarized in the IS. Our subconsultant, Tracer Environmental Sciences & Technologies, Inc., would be responsible for conducting the dispersion modeling to assess the offsite consequences of a chlorine release, the results of which would be incorporated Xx. Xxxx Xxxxxxx and Xx. Xxxxxx Xxxxxx October 24, 2008 into the IS. K2 Pure Solutions’ subconsultant, Yorke, would be responsible for conducting the air permitting work as well as for preparing the air quality section of the IS document. Our proposal is based on Yorke’s providing a complete air quality IS section (including a greenhouse gas emissions analysis) to ICF Xxxxx & Xxxxxx within one week of their receiving the project traffic study. The IS would be consistent in form and content with the California Office of Planning and Research Environmental Checklist Form in Appendix G of the CEQA Guidelines. ICF Xxxxx & Xxxxxx would prepare responses to each checklist question, which would include quantitative analyses of the proposed project’s air, noise, traffic, water supply, chlorine dispersion, and public utilities impacts. ICF Xxxxx & Xxxxxx would also prepare qualitative analyses of the project’s aesthetic, biological resources, cultural resources, geology and soils, hazards and hazardous materials, hydrology and water quality, land use and planning, mineral resources, public services, and recreation impacts. It is assumed that detailed analyses of the project’s construction and operational air quality analyses, including a health risk assessment, would be prepared by Yorke Engineering, LLC, under separate contract to K2 Pure Solutions. ICF Xxxxx & Xxxxxx staff would independently review the adequacy of the air quality analysis and health risk assessment on behalf of the City and would incorporate the results in the IS and CEQA documentation. It is also assumed that information on existing contamination and geotechnical conditions of the proposed project site would be provided by K2 Pure Solutions or DOW Chemical Company to ICF Xxxxx & Xxxxxx for use in completing the IS. ICF Xxxxx & Xxxxxx would prepare a bri...
Sample 1
Initial Study. Three years after the assumption of management by the Trust, the General Accounting Office shall conduct an interim study of the activities of the Trust and shall report the results of the study to the Committees of Congress. The study shall include, but shall not be limited to, details of programs and activities operated by the Trust and whether it met its obligations under this title.
Sample 1
Initial Study. Biosense shall be responsible for, or reimburse Rexahn for, as applicable, all costs of conducting the Initial Study other than the costs and expenses associated with the supply of RX-3117, which costs and expenses shall be allocated between the Parties in accordance with Section 2.6.
Sample 1
Initial Study. All analyses used the Statistical Package for the Social Sciences (SPSS® 14 for Windows). Group data was reported using means (standard deviations) and ranges. The inter relationships between tender points and measures of disease activity were assessed using bivariate Xxxxxxxx’x correlations. To determine the factors influencing tender points, simple regression was followed by backwards stepwise multiple regression using tender points as the dependent variable. To determine the impact of tender points on patient outcomes, the patients were divided into two groups according to the number of positive tender points used in the diagnosis of fibromyalgia; those with 11 or more positive tender points and those with 10 or less positive tender points. To determine if tender minus swollen joint counts could identify fibromyalgic RA as accurately as tender points, Receiver Operator Characteristic (ROC) analysis was employed. ROC curve analyses are used in medicine to determine a cut-off value for a clinical test. This is a statistical approach to try and distinguish “normal” from “abnormal”. [Xxxxxx et al. 1994] The ROC curve is a graph of sensitivity vs.
Sample 1
Initial Study. The De Novo team will prepare an Initial Study (IS) to address potential impacts associated with the proposed project. The Initial Study would be prepared consistent with requirements of CEQA, and Appendix G of the CEQA Guidelines. This will specifically include: Project background, Description of project, Project setting, Affected Agencies, Environmental factors potentially affected, Environmental determination, Project and vicinity maps, Evaluation of environmental impacts (environmental checklist). We understand that the City has a conceptual plan and has requested a variety of technical studies to support an Initial Study/MND. These include: Phase 1 Environmental Study, Air Quality Impact Analysis, Biology Study, Extended XXXXX Records Search on all parcels, Historical resources evaluation, Geotechnical Report, Noise Study, Traffic Impact Study, and Water Supply Assessment. We have included all of these for use in the CEQA document; however, we recommend that a geotechnical report be prepared for a more specific design at the improvement plan phase of the project. We will instead into a planning level review of the soils within the boundary of the site. We feel that a design-level geotechnical evaluation should be done once more detail is known; however, at the request of the City we can add this as additional scope. Task 2.2
Sample 1
AutoNDA by SimpleDocs
Initial Study. CONSULTANT shall perform an initial environmental study. The initial study shall follow the CITY’s initial study template found at the link xxxx://xxx.xxxxxxxxx.xxx/planning/eir/ConsultantPage.asp. Upon review of the initial study, the CITY’s Planning Department will determine the type of declaration or if an EIR is required. To complete the initial study, CONSULTANT shall complete the following:
Sample 1
Initial Study. A study of a Completed Application conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Section 19 or Section 32 of the Tariff.
Sample 1

Related to Initial Study

  • Feasibility Study Buyer will, at Buyer's expense and within ____ days from Effective Date ("Feasibility Study Period"), determine whether the Property is suitable, in Buyer's sole and absolute discretion, for ___________________ use. During the Feasibility Study Period, Buyer may conduct a Phase I environmental assessment and any other tests, analyses, surveys and investigations ("Inspections") that Buyer deems necessary to determine to Buyer's satisfaction the Property's engineering, architectural and environmental properties; zoning and zoning restrictions; subdivision statutes; soil and grade; availability of access public roads, water, and other utilities; consistency with local, state and regional growth management plans, availability of permits, government approvals, and licenses; and other inspections that Buyer deems appropriate to determine the Property's suitability for the Buyer's intended use. If the Property must be rezoned, Buyer will obtain the rezoning from the appropriatx xxxernment agencies. Seller will sign all documents Buyer is required to file in connection with development or rezoning approvals. Seller gives Buyer, its agents, contractors and assigns, the right to enter the Property at any time during the Feasibility Study Period for the purpose of conducting inspections; provided, however, that Buyer, its agents, contractors and assigns enter the Property and conduct inspections at their own risk. Buyer will indemnify and hold Seller harmless from xxxxes, damages, costs, claims and expenses of any nature, including attorney's fees, expenses and liability incurred in application for rezoning or related proceedings, and from liability to any person, arising from the conduct of any and all inspections of any work authorized by Buyer. Buyer will not engage in any activity that xxxxx result in a construction lien being filed against the Property without Seller's prior written consent. If this transaction does not close, Buyer will, at Buyer's expense, (1) repair all damages to the Property resulting from the Inspections and return the Property to the condition it was in prior to conduct of the Inspections, and (2) release to Seller all reports and other work generated as a result of the Inspections. Buyer will deliver written notice to Seller prior to the expiration of the Feasibility Study Period of Buyer's determination of whether or not the Properxx xx acceptable. Buyer's failure to comply with this notice requirement will constitute acceptance of the Property as suitable for Buyer's intended use in its "as is" condition. If the Property is unacceptable to Buyer and written notice of this fact is timely delivered to Seller, this Contract will be deemed terminated as of the day after the Feasibility Study period ends and Buyer's deposit(s) will be returned after Escrow Axxxx receives proper authorization form all interested parties.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Research Program Funding 3.1.1 Pfizer will fund the research to be performed by Rigel, pursuant to the Agreement, according to the following schedule: COMMITMENT YEAR ANNUAL COMMITMENT 1 $2,350,000.00 2 $2,350,000.00 The funding payments of two million three hundred and fifty thousand dollars ($2,350,000.00) shall support the work of the equivalent of ten (10) full time employees ("FTEs") of Rigel.

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Phase II A small portion of the work for the Phase II modifications to the Plattsburgh Substation will be performed by Transmission Owner, and the remainder will be performed by Clinton and Xxxxxxxxx. A detailed definition of the specific scope for Transmission Owner and Clinton and Xxxxxxxxx including interface points shall be defined during the design phase and, as such documents become available, copies will be delivered to the NYISO, Transmission Owner, Noble Altona Windpark, LLC and Marble River, LLC. The full scope includes the installation of wave traps, CCVT’s and modifications and/or additions to relaying on the MWP-1 and MWP- 2 lines. These lines will be reconfigured at the completion of Phase II to connect to Xxxxx and Xxxxxxx Substations on MWP-1 and the Xxxx Substation on MWP-2. Clinton and Xxxxxxxxx will design the upgrades and purchase the materials based on the outline specification that was prepared and issued by Transmission Owner. The work to be performed by Clinton and Xxxxxxxxx will include both the materials for the exterior and interior installations and items for Transmission Owner installation inside the control building in existing relay panels and communication racks. In addition, Clinton and Xxxxxxxxx will be responsible for the exterior and interior construction work and will provide construction management services in coordination with Transmission Owner. The civil design for the foundations and the electrical design for the cable runs to the control room will be designed by, as approved by Transmission Owner, and installed under the supervision and control of Clinton and Xxxxxxxxx. The equipment will be selected and procured in accordance with the specifications developed during the detailed engineering phase, copies of which shall be furnished to the NYISO, Transmission Owner, Noble Altona Windpark, LLC and Marble River, LLC. The construction of the foundations, structures, wave traps, CCTV and cable runs into the control building to the termination cabinets will be completed by Clinton and Xxxxxxxxx. The work at the Plattsburgh Substation will be installed under Transmission Owner’s CPP-1. Transmission Owner will provide Protection and Controls Engineering, install and terminate wiring from the termination cabinets to the control panels and relays, install relays and equipment in the existing panels, and will commission such work inside the 230kV control building. Transmission Owner will develop the communications protocols and data flow over the circuits.

Time is Money Join Law Insider Premium to draft better contracts faster.